NDAQ Stock Rises 1.6% in a Year: A Signal for Investors to Hold Tight?

Zacks
Abrir en Zacks
NDAQ Stock Rises 1.6% in a Year: A Signal for Investors to Hold Tight?

Shares of Nasdaq, Inc. NDAQ have gained 1.6% over the past year, outperforming the industry's 15.9% decline. 

Arch Capital has outperformed its peers, including Intercontinental Exchange Inc. ICE, CME Group Inc. CME and OTC Markets Group Inc. OTCM. Shares of ICE, CME and OTCM have lost 23.1%, 11.7% and 8.5%, respectively, in the past year.

Zacks Investment Research
Image Source: Zacks Investment Research

With a market capitalization of $51.66 billion, the average volume of shares traded in the last three months was 3.9 million. NDAQ has a solid track record of beating earnings estimates in each of the last four quarters, with an average of 4.93%.

NDAQ Trading Above 50-Day and 200-Day Moving Averages

Shares of Nasdaq closed at $91.36 on Wednesday and are trading above the 50-day and 200-day simple moving averages (SMA) of $87.40 and $88.96, respectively, indicating solid upward momentum. SMA is a widely used technical analysis tool to predict future price trends by analyzing historical price data.

Zacks Investment Research
Image Source: Zacks Investment Research

NDAQ’s Growth Projection Encourages

The Zacks Consensus Estimate for Nasdaq’s 2026 earnings per share indicates a year-over-year increase of 12.3%. The consensus estimate for revenues is pegged at $5.78 billion, implying a year-over-year improvement of 10.1%. 

The consensus estimate for 2027 earnings per share and revenues indicates an increase of 12.7% and 7.7%, respectively, from the corresponding 2026 estimates. 

The long-term earnings growth is expected to be 16%, better than the industry average of 12.5%.

Optimist Analyst Sentiment on NDAQ

Six of the 11 analysts covering the stock have raised estimates for 2026, and five analysts have raised the same for 2027 over the past 30 days. Thus, the Zacks Consensus Estimate for 2026 and 2027 earnings has moved up 0.7% and 1.4%, respectively, in the past 30 days.

Average Target Price for NDAQ Suggests Upside

Based on short-term price targets offered by 17 analysts, the Zacks average price target is $107.88 per share. The average suggests a potential 22.58% upside from the last closing price.

Zacks Investment Research
Image Source: Zacks Investment Research

Nasdaq’s Favorable Return on Capital

Return on equity in the trailing 12 months was 17.5%, better than the industry average of 16%. This highlights the company’s efficiency in utilizing shareholders’ funds. 

Also, the return on invested capital (ROIC) has been increasing over the last few quarters as the company raised its capital investment over the same time frame, reflecting NDAQ’s efficiency in utilizing funds to generate income. ROIC in the trailing 12 months was 7.9%, better than the industry average of 6.6%.

Key Points to Note for NDAQ Stock

Nasdaq’s organic growth has also been aided by its strategy of accelerating its non-trading revenue base, which includes Trading Services and Marketplace Technology businesses, Data & Listing Services, Index and Workflow & Insights businesses, and Anti-Financial Crime business, thereby infusing dynamism into its business profile. 

Growth in non-trading segments was driven by higher Index revenues, demand for IR and ESG solutions, steady analytics solutions sales to asset managers, and increasing recurring data revenues. Anti-Financial Crime revenues should continue to gain from solid demand for fraud detection and anti-money laundering solutions, as well as the SaaS-based surveillance solutions.

Nasdaq focuses on cross-selling multiple products to existing clients and integrating acquisitions to broaden its solutions portfolio, thereby increasing customer stickiness and revenue visibility.

Nasdaq has grown meaningfully over the years through several strategic expansions. These acquisitions have helped the company gain direct access to the Canadian equities market, expand its technology offering and improve its market surveillance techniques.

Nasdaq boasts a healthy balance sheet and cash position, along with modest operating cash flow from its diverse business model. A healthy balance sheet ensures the distribution of wealth to shareholders in the form of dividend hikes and share repurchases.

Conclusion

Nasdaq is set to grow on impressive organic growth, an increasing on-trading revenue base and strategic buyouts to capitalize on market opportunities. The company’s focus on Market Technology and Information Services businesses helps explore vast opportunities through its developmental strategies.

NDAQ’s dividend story is impressive. Per its growth strategy, Nasdaq will bring the payout ratio of 35-38% by 2027 and resume share buybacks to offset dilution from the Adenza buyout. 

Higher return on capital, favorable growth estimates and attractive valuations should continue to benefit NDAQ over the long term.

It is, therefore, wise to hold on to this Zacks Rank #3 (Hold) stock at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Nasdaq, Inc. (NDAQ): Free Stock Analysis Report
 
Intercontinental Exchange Inc. (ICE): Free Stock Analysis Report
 
CME Group Inc. (CME): Free Stock Analysis Report
 
OTC Markets Group Inc. (OTCM): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research